Table 6.
SC (n=884) | EAC (n=888) | % Difference (one-sided 95% CI) | One-sided P value | |
All cancers | ||||
Global | 20 (2.3%) | 36 (4.1%) | 1.8 % (0.4% to ∞) | 0.02 |
Non-BCSP | 5 (1.0%) | 10 (2.0%) | 1.0 % (−0.3% to ∞) | 0.11 |
BCSP | 15 (3.7%) | 26 (6.6%) | 2.9 % (0.3% to ∞) | 0.03 |
Endoscopically detected cancers | ||||
Global | 19 (2.2%) | 32 (3.6%) | 1.5% (0.1% to ∞) | 0.03 |
Non-BCSP | 4 (0.8%) | 9 (1.8%) | 1.0 % (−0.2% to ∞) | 0.09 |
BCSP | 15 (3.7%) | 23 (5.8%) | 2.1 % (−0.3% to ∞) | 0.08 |
Polyp cancers | ||||
Global | 1 (0.1%) | 4 (0.5%) | 0.3 % (−0.1% to ∞) | 0.09 |
Non-BCSP | 1 (0.2%) | 1 (0.2%) | 0.0 % (−0.5% to ∞) | 0.51 |
BCSP | 0 (0.0%) | 3 (0.8%) | 0.8 % (0.0% to ∞) | 0.04 |
BCSP, Bowel Cancer Screening Programme; EAC, EV-assisted colonoscopy; SC, standard colonoscopy.